These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3641 related articles for article (PubMed ID: 11832252)

  • 41. Screening instruments for anxiety and depression in patients with irritable bowel syndrome are ambiguous.
    Larsen AR; Engsbro AL; Bytzer P
    Dan Med J; 2014 Feb; 61(2):A4785. PubMed ID: 24495890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12.
    Le Fevre P; Devereux J; Smith S; Lawrie SM; Cornbleet M
    Palliat Med; 1999 Sep; 13(5):399-407. PubMed ID: 10659112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for mental disorders in leprosy patients: comparing the internal consistency and screening properties of HADS and GHQ-12.
    Senturk V; Stewart R; Sagduyu A
    Lepr Rev; 2007 Sep; 78(3):231-42. PubMed ID: 18035774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospital anxiety and depression scale assessment of 100 patients before and after using low vision care: A prospective study in a tertiary eye-care setting.
    Rishi P; Rishi E; Maitray A; Agarwal A; Nair S; Gopalakrishnan S
    Indian J Ophthalmol; 2017 Nov; 65(11):1203-1208. PubMed ID: 29133652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients.
    Bunevicius A; Staniute M; Brozaitiene J; Bunevicius R
    J Psychosom Res; 2012 Jan; 72(1):22-5. PubMed ID: 22200518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis.
    Mitchell AJ; Meader N; Symonds P
    J Affect Disord; 2010 Nov; 126(3):335-48. PubMed ID: 20207007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bifactor analysis and construct validity of the HADS: a cross-sectional and longitudinal study in fibromyalgia patients.
    Luciano JV; Barrada JR; Aguado J; Osma J; García-Campayo J
    Psychol Assess; 2014 Jun; 26(2):395-406. PubMed ID: 24295235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reliability and validity of the Malayalam hospital anxiety and depression scale (HADS) in cancer patients.
    Thomas BC; Devi N; Sarita GP; Rita K; Ramdas K; Hussain BM; Rejnish R; Pandey M
    Indian J Med Res; 2005 Nov; 122(5):395-9. PubMed ID: 16456252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer.
    Fosså SD; Dahl AA
    J Psychosom Res; 2002 Feb; 52(2):79-87. PubMed ID: 11832253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limited validity of the Hospital Anxiety and Depression Scale (HADS) in dementia: evidence from a confirmatory factor analysis.
    Stott J; Spector A; Orrell M; Scior K; Sweeney J; Charlesworth G
    Int J Geriatr Psychiatry; 2017 Jul; 32(7):805-813. PubMed ID: 27352820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.
    Stafford L; Judd F; Gibson P; Komiti A; Quinn M; Mann GB
    Gen Hosp Psychiatry; 2014; 36(1):74-80. PubMed ID: 24200105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.
    Stafford L; Berk M; Jackson HJ
    Gen Hosp Psychiatry; 2007; 29(5):417-24. PubMed ID: 17888808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The psychometric properties, sensitivity and specificity of the geriatric anxiety inventory, hospital anxiety and depression scale, and rating anxiety in dementia scale in aged care residents.
    Creighton AS; Davison TE; Kissane DW
    Aging Ment Health; 2019 May; 23(5):633-642. PubMed ID: 29470096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey.
    Terluin B; Smits N; Brouwers EP; de Vet HC
    Health Qual Life Outcomes; 2016 Sep; 14(1):130. PubMed ID: 27629535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in individuals with stable chronic obstructive pulmonary disease (COPD): a systematic review.
    Nikolovski A; Gamgoum L; Deol A; Quilichini S; Kazemir E; Rhodenizer J; Oliveira A; Brooks D; Alsubheen S
    Disabil Rehabil; 2024 Apr; 46(7):1230-1238. PubMed ID: 36861817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the Polish version of the Hospital Anxiety and Depression Scale for anxiety disorders in patients with epilepsy.
    Wiglusz MS; Landowski J; Cubała WJ
    Epilepsy Behav; 2018 Jul; 84():162-165. PubMed ID: 29803946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for anxiety and depression in patients with glaucoma.
    Mabuchi F; Yoshimura K; Kashiwagi K; Yamagata Z; Kanba S; Iijima H; Tsukahara S
    Br J Ophthalmol; 2012 Jun; 96(6):821-5. PubMed ID: 22353697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
    Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients.
    Chan CYY; Tsang HHL; Lau CS; Chung HY
    Int J Rheum Dis; 2017 Mar; 20(3):317-325. PubMed ID: 25293872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability and Validity of a Nepali-language Version of the Hospital Anxiety and Depression Scale (HADS).
    Risal A; Manandhar K; Linde M; Koju R; Steiner TJ; Holen A
    Kathmandu Univ Med J (KUMJ); 2015; 13(50):115-24. PubMed ID: 26657079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 183.